Calculate lung-nodule volume doubling time and compare it with Fleischner and Lung-RADS reference frameworks in a follow-up worksheet.
Lung nodules are common on chest CT, and most are benign. The hard part is deciding which interval changes are meaningful enough to deserve closer follow-up. **Volume doubling time (VDT)** is one way to quantify that change by asking how quickly the estimated nodule volume doubles over time.
The relationship between diameter and volume is cubic: a seemingly small increase in diameter can reflect a much larger volumetric change. That is why volumetric analysis is often more informative than diameter alone, even though diameter-based sphere estimates remain common when direct CT volumetry is unavailable.
Clinical management of lung nodules uses structured follow-up frameworks. The **Fleischner Society 2017 guidelines** apply to incidentally detected nodules, while **Lung-RADS** is used for screening programs. This calculator keeps the VDT arithmetic and those reference frameworks together, but it should be treated as a follow-up worksheet, not as a stand-alone malignancy or biopsy decision tool.
Lung nodule growth rate is one of the most useful clues for deciding whether a nodule deserves closer imaging follow-up or invasive workup. This calculator keeps the measurements, interval, and guideline context together so growth can be judged consistently instead of by eye alone.
Volume from diameter: V = πd³/6 (sphere). Volume Doubling Time: VDT = (Δdays × ln2) / ln(V₂/V₁). Annual growth rate = ((V₂/V₁)^(365/Δdays) − 1) × 100%. Malignant VDT typically 100–400 days.
Result: VDT = 153 days — concerning growth pattern
Initial volume = 268 mm³, follow-up = 524 mm³ (95% increase). VDT = (180 × ln2)/ln(524/268) = 153 days. That kind of growth rate is often considered concerning in a persistent solid nodule, but the next step still depends on morphology, screening context, and specialist review.
A single diameter measurement can be reassuring or alarming depending on the scan technique and the nodule's shape. Growth rate gives the change a time dimension, which is why volume doubling time is so useful when a nodule sits near a follow-up threshold.
Fleischner and Lung-RADS do not use growth in isolation. Nodule size, morphology, smoking history, and whether the nodule is solid or subsolid all change what the same VDT means in practice. That is why the calculator pairs the numeric result with the follow-up framework rather than presenting a stand-alone value.
Small changes can fall within CT variability, especially when the slice thickness, reconstruction kernel, or measurement plane changes between scans. The value is most useful when the same technique is used on both studies and the trend is confirmed on more than one follow-up exam.
Last updated:
This page estimates nodule growth either from direct volumetric measurements or, when only diameter is available, from a sphere-based volume approximation. It then computes volume doubling time and places the result next to commonly used reference frameworks such as Fleischner 2017 and Lung-RADS. The output is intentionally framed as follow-up context only. Growth rate by itself does not diagnose malignancy, and the result should be interpreted with morphology, technique consistency, symptoms, screening status, and specialist review.
Malignant solid lung nodules typically have VDT between 100–400 days. VDT < 30 days more likely represents infection. VDT > 600 days is usually benign.
A 26% increase in diameter doubles the volume. Small diameter changes can be within measurement error, while volumetric changes more sensitively detect true growth.
GGNs grow much more slowly and may represent adenocarcinoma in situ or minimally invasive adenocarcinoma. VDT cutoffs for GGNs are different — even VDTs of 600+ days may be malignant.
Per Fleischner 2017: solid nodules < 6 mm in low-risk patients need no follow-up. Nodules 6–8 mm need CT at 6–12 months. Nodules > 8 mm need 3-month CT, PET, or biopsy.
Part-solid nodules have both ground-glass and solid components. Despite being an intermediate pattern, they actually have the highest rate of malignancy (~63% if persistent and > 8 mm).
Lung nodules are rarely perfect spheres, so diameter-based volume estimates have inherent error. Using the average of long and short axes helps, but direct CT volumetry is more accurate.